首页> 外文期刊>The British journal of general practice: the journal of the Royal College of General Practitioners >Diagnosing cancer in primary care: results from the National Cancer Diagnosis Audit
【24h】

Diagnosing cancer in primary care: results from the National Cancer Diagnosis Audit

机译:在初级保健中诊断癌症:国家癌症诊断审核的结果

获取原文
           

摘要

Background Continual improvements in diagnostic processes are needed to minimise the proportion of patients with cancer who experience diagnostic delays. Clinical audit is a means of achieving this.Aim To characterise key aspects of the diagnostic process for cancer and to generate baseline measures for future re-audit.Design and setting Clinical audit of cancer diagnosis in general practices in England.Method Information on patient and tumour characteristics held in the English National Cancer Registry was supplemented by information from GPs in participating practices. Data items included diagnostic timepoints, patient characteristics, and clinical management.Results Data were collected on 17 042 patients with a new diagnosis of cancer during 2014 from 439 practices. Participating practices were similar to non-participating ones, particularly regarding population age, urban/rural location, and practice-based patient experience measures. The median diagnostic interval for all patients was 40 days (interquartile range [IQR] 15–86 days). Most patients were referred promptly (median primary care interval 5 days [IQR 0–27 days]). Where GPs deemed diagnostic delays to have occurred (22% of cases), patient, clinician, or system factors were responsible in 26%, 28%, and 34% of instances, respectively. Safety netting was recorded for 44% of patients. At least one primary care-led investigation was carried out for 45% of patients. Most patients (76%) had at least one existing comorbid condition; 21% had three or more.Conclusion The findings identify avenues for quality improvement activity and provide a baseline for future audit of the impact of 2015 National Institute for Health and Care Excellence guidance on management and referral of suspected cancer.
机译:背景技术需要持续改进诊断过程以使经历诊断延迟的癌症患者的比例最小化。临床审核是实现此目标的一种方法。目的是表征癌症诊断过程的关键方面,并为将来的重新审核制定基准措施;设计和设置英格兰一般实践中的癌症诊断临床审核方法。参与实践的全科医生提供的信息补充了英国国家癌症注册中心(NHS)拥有的肿瘤特征。数据项包括诊断时间点,患者特征和临床管理。结果数据收集自2014年以来439种实践中的17042例癌症新患者。参与实践与非参与实践相似,特别是在人口年龄,城市/农村地区以及基于实践的患者体验测度方面。所有患者的平均诊断间隔为40天(四分位间距[IQR] 15-86天)。大多数患者应及时转诊(中位初级保健间隔5天[IQR 0–27天])。 GP认为发生诊断延迟(占病例的22%)时,分别有26%,28%和34%的病例是由患者,临床医生或系统因素造成的。记录了44%的患者的安全网。至少一项针对45%的患者的初级保健指导的研究。大多数患者(76%)至少有一种合并症。 21%的人有三个或三个以上。结论研究结果确定了质量改进活动的途径,并为将来审核《 2015年美国国家卫生与护理卓越研究院指南》对可疑癌症的管理和转诊的影响提供了基准。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号